Yissum-based company ChickP, founded in 2016, out of a discovery made over several years previous by Professor Ram Reifen that the physical development of children in the villages of Ethiopia, Uganda and Kenya was different to that of those growing up in the bigger cities.

Check out this French article on Yissum's technologies and successes over the recent years.

Our portfolio company, Nectin Therapeutics, has announced that it is testing its breakthrough immuno-oncology cancer treatment on patients.

“The ability to produce dairy components from plants has the potential to change the dairy industry and positively impact the world as a whole."

The partnership will make Smart Resilin's technology available to Acies Bio to develop and deliver resilin at scale for sustainable applications in a multitude of industries, from beauty to aerospace.

A new process that significantly improves manufacturing efficiency and lowers the cost of producing cultured chicken was just published in the journal Nature Foods.

EduCann will give doctors, nurses and pharmacists around the world the ability to treat patients more effectively with medical cannabis.

Airovation Technologies’ MOU with Kolon is precisely the kind of partnership that will propel the broader Israel-South Korea relationship to new heights.

SpliSense announced the initiation of a Phase I/II trial assessing SPL84, the company’s lead antisense oligonucleotide (ASO).

“Our facility propels Believer forward as a leader in the cultivated meat industry,” Nicole Johnson-Hoffman, Believer’s CEO said in a statement. “

ChickP Protein, a Hebrew University food-tech startup, has introduced a chickpea protein isolate for plant-based ice cream.

WIRED’s deputy global editorial director, Greg Williams spoke with Professor Yaakov Nahmias, founder of Tissue Dynamics, regarding the future of drug development and how it is dramatically increasing clinical success rates by using sensor-driven discovery.